Donanemab in Early Symptomatic Alzheimer Disease

Thread Tools

Display Modes

07-18-2023, 02:44 PM

Lara

Legendary

Join Date: Sep 2006

Location: 16.9203° S, 145.7710° E

Posts: 11,010

Lara

Legendary

Join Date: Sep 2006

Location: 16.9203° S, 145.7710° E

Posts: 11,010

Donanemab in Early Symptomatic Alzheimer Disease

JAMA. Published online July 17, 2023. doi:10.1001/jama.2023.13239
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial | Dementia and Cognitive Impairment | JAMA | JAMA Network

Original Investigation
July 17, 2023
Donanemab in Early Symptomatic Alzheimer Disease
The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
________________
Seems as if there's positive conclusions.

Also noted the conflict in interest disclosures and funding and support.

So far looks promising however. I hope so

Reply With Quote

Tags

alzheimer, disease, donanemab, july, symptomatic

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
We may be able to reverse signs of early Alzheimer’s disease	badboy99	Parkinson's Disease	0	12-08-2014 11:34 AM
Early Alzheimer's Disease from head trauma	kittycapucine1974	Alzheimer's Disease	1	10-17-2011 03:09 PM

All times are GMT -5. The time now is 12:53 PM.

NeuroTalk Forums

Helping support those with neurological and related conditions.

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Site Navigation

NeuroTalk Online Support Groups

Donanemab in Early Symptomatic Alzheimer Disease

NeuroTalk Forums